Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study - Concepedia

Concepedia

Publication | Open Access

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

DOI Full Paper Access

301

Citations

29

References

2010

Year

Giuseppe Colucci, Roberto Labianca, Francesco Di Costanzo, Vittorio Gebbia, Giacomo Cartenì, B. Massidda, E. Dapretto, Luigi Manzione, Elena Piazza, Mirella Sannicolò,

Journal of Clinical Oncology

Abstract

The addition of weekly cisplatin to gemcitabine failed to demonstrate any improvement as first-line treatment of advanced pancreatic cancer.

References

	Year	Citations

Page 1